Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Analogs”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Post-approval studies (Phase 4)Study completedNCT01618513
What this trial is testing

Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target

Who this might be right for
Acromegaly
University of Aarhus 84
Post-approval studies (Phase 4)Study completedNCT00376064
What this trial is testing

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT01620138
What this trial is testing

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Who this might be right for
Non-functioning Pituitary AdenomasProlactinomas
Universidade Federal do Rio de Janeiro 21
Large-scale testing (Phase 3)WithdrawnNCT01860742
What this trial is testing

Randomized Phase III of PRRT Versus Interferon

Who this might be right for
Gastro-intestinal Neuroendocrine Tumors
Jules Bordet Institute
Testing effectiveness (Phase 2)Study completedNCT02217800
What this trial is testing

The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics

Who this might be right for
Acromegaly
Aspireo Pharmaceuticals Limited 8
Early research (Phase 1)Study completedNCT00446082
What this trial is testing

Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease

Who this might be right for
Carcinoid TumorAcromegaly
Novartis Pharmaceuticals 85
Large-scale testing (Phase 3)Looking for participantsNCT06930625
What this trial is testing

Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Who this might be right for
Acromegaly
Debiopharm International SA 119
Testing effectiveness (Phase 2)UnknownNCT03629847
What this trial is testing

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

Who this might be right for
Neuroendocrine Tumors
King Faisal Specialist Hospital & Research Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04837885
What this trial is testing

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases

Who this might be right for
Neuroendocrine TumorLiver MetastasesNeuroendocrine Gastroenteropancreatic Tumour
University Hospital, Bordeaux 23
Not applicableStudy completedNCT00652379
What this trial is testing

Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients

Who this might be right for
AcromegalyInsulin ResistanceImpaired Glucose Tolerance
University of Aarhus 18
Early research (Phase 1)UnknownNCT04138342
What this trial is testing

Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast Cancer

Who this might be right for
Breast CancerSkin CancerSkin Diseases
Al-Azhar University 30
Testing effectiveness (Phase 2)Study completedNCT01670110
What this trial is testing

Pasireotide LAR in Severe Polycystic Liver Disease

Who this might be right for
Somatostatin AnalogsPolycystic Liver DiseaseAutosomal Dominant Polycystic Kidney Disease+1 more
Mayo Clinic 48
Testing effectiveness (Phase 2)UnknownNCT01203306
What this trial is testing

Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Carcinomas
University of Turin, Italy 42
Large-scale testing (Phase 3)Study completedNCT01412424
What this trial is testing

Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly

Who this might be right for
Acromegaly
Chiasma, Inc. 155
Post-approval studies (Phase 4)Study completedNCT01070758
What this trial is testing

Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy

Who this might be right for
Congenital Hyperinsulinism
Sheba Medical Center 3
Post-approval studies (Phase 4)Study completedNCT03289741
What this trial is testing

Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide

Who this might be right for
Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center 51
Not applicableApproved For MarketingNCT02705313
What this trial is testing

EAP 177Lu-DOTA0-Tyr3-Octreotate for Inoperable, SSR+, NETs, Progressive Under SSA Tx

Who this might be right for
Neuroendocrine Tumors
Advanced Accelerator Applications
Not applicableStudy completedNCT01732406
What this trial is testing

Acromegaly Treatment Quality of Life Study

Who this might be right for
Acromegaly
Massachusetts General Hospital 126
Large-scale testing (Phase 3)Study completedNCT00331188
What this trial is testing

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Who this might be right for
Esophageal VaricesPortal HypertensionGastric Varices+1 more
Debiovision 70
Testing effectiveness (Phase 2)Study completedNCT01128192
What this trial is testing

Somatostatin Analogue SOM230 (Pasireotide) in Healthy Male Volunteers

Who this might be right for
Hyperglycemia
Robert R. Henry, MD 45
Load More Results